BeyondSpring Pharmaceuticals: Communicating across US-China lines
August 07, 2017
Newly listed immuno-oncology firm on its post-IPO goals, small-cap challenges and drugs trials in the US and China
Dr Lan Huang is co-founder, chairman and CEO of a New York-headquartered clinical-stage company within a regulatory framework that sees the firm conduct trials both in the US, where the company is based and listed, and in China.
‘We have a robust pipeline from